Cover Image
Market Research Report

Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Published by IMARC Services Private Limited Product code 945224
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
Published: June 18, 2020 Content info: 110 Pages
Description

The global human growth hormone market (HGH) is currently witnessing strong growth. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 6% during 2020-2025.

Breakup by Application:

  • Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature (ISS)
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by Route of Administration:

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report:

  • How has the global human growth hormone market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human growth hormone market and who are the key players?
  • What is the degree of competition in the industry?
Table of Contents
Product Code: SR1019J25_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Market Types
      • 6.1.2.2 Market Types
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.1 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.1 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.1 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.1 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.1 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2019
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2019
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2019
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: China: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: India: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: France: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 77: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 78: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players
Back to Top